Merrimack Pharmaceuticals Inc Net Income per Employee (MACK), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Merrimack Pharmaceuticals Inc  (NASDAQ: MACK)
 

Merrimack Pharmaceuticals Inc Net Income per Employee

MACK's Quarterly Results, Trends, Rankings, Statistics
Merrimack Pharmaceuticals Inc's Income per employee grew in the first quarter 2024 on a trailing twelve month basis to $ 1,713,333, the income was higher than average, indicating higher productivity of the company's employees.
The Healthcare sector has seen employees of 7 other companies achieving higher income per employee. While Merrimack Pharmaceuticals Inc's total ranking has deteriorated compared to the previous quarter from 0 to 123.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MACK Net Income per Employee (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ 1,713,333 -10,094 -12,248 -13,641 -14,385
MACK's Total Ranking # 123 # 0 # 0 # 0 # 0
Seq. Net Income Change - - - - -

MACK Company Profile >> Back to MACK Efficiency Comparisons >> Compare MACK Net Income per Employee to its Competitors

MACK Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 9
Overall Market # 123

Net Income per Employee Statistics
High Average Low
$ 4,130,248 $ -88,070 $ -1,539,060
(Mar 31 2018)   (Jun 30 2016)







Companies with similar Income per Employee for 12 month ending Mar 31 2024, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2024Number of Employees Mar 31 2024
Ligand Pharmaceuticals Incorporated  2,049,872.34 $ 96.344  Million 47 
Merrimack Pharmaceuticals Inc  1,713,333.33 $ 200.460  Million 117 
Evofem Biosciences Inc   1,637,689.66 $ 47.493  Million 29 
Siga Technologies Inc  1,617,641.24 $ 79.264  Million 49 
Oramed Pharmaceuticals Inc  1,497,461.54 $ 19.467  Million 13 
Biomx Inc  1,307,650.00 $ 26.153  Million 20 
Protagonist Therapeutics inc   1,228,106.06 $ 162.110  Million 132 
Camp4 Therapeutics Corporation  1,175,625.00 $ 56.430  Million 48 
Innoviva Inc   1,140,811.32 $ 181.389  Million 159 
Spero Therapeutics Inc   936,120.00 $ 23.403  Million 25 


Date modified: 2026-09-12T06:14:30+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.